# Fleury Expands in Women’s Health With R$207 Million FEMME Deal

*São Paulo-based diagnostic group deepens focus on premium niche; acquisition adds 12 units and R$286 million in revenue.*

- Published: 2025-11-04
- Section: Insights
- URL: https://brazilstockguide.com/insights/fleury-acquires-femme-laboratorio-da-mulher-for-207-million/

![Fleury, Health Care](https://i0.wp.com/brazilstockguide.com/wp-content/uploads/2025/10/17773400-4089-11ef-b816-13709e2f71e7-Campinas-009-e1760962224181.jpg?fit=1024%2C683&ssl=1)

*Fleury, Health Care*

**By Brazil Stock Guide –** Fleury S.A. (B3: FLRY3) announced the acquisition of **FEMME Laboratório da Mulher**, a São Paulo-based diagnostics network specializing in women’s health, for an enterprise value of **R$207.5 million**, marking its latest move in a sector consolidation strategy. FEMME, owned by **GIP Medicina Diagnóstica S.A.**, reported **R$286.6 million in gross revenue in 2024** from 12 clinics focused on gynecological, imaging, and preventive careFleury.

The transaction, structured at **0.7x EV/revenue and 5.5x EV/EBITDA**, falls to **3.3x EV/EBITDA** when synergies are factored in, according to Fleury’s statement to investors. The company emphasized that the deal strengthens its presence in São Paulo’s premium healthcare segment, following a series of targeted expansions in diagnostics and personalized medicineFleury.

**“The acquisition of FEMME reinforces our leadership in high-complexity and women’s health services,”** said **José Antonio de Almeida Filippo**, Fleury’s CFO and Investor Relations Officer, in the filing. The company will submit the transaction for **CADE’s antitrust review** and a **shareholder ratification**, as required by Article 256 of Brazil’s corporate law.

The deal underlines Fleury’s broader push to integrate specialized outpatient networks and enhance its scale in niche medical segments — a trend gaining pace amid competitive pressure from rivals like Dasa and Alliar. With FEMME, Fleury adds a recognized brand with loyal clientele, aligning with its strategy to capture higher-margin diagnostic demand and expand its ecosystem of integrated healthcare services.

---

Source: Brazil Stock Guide, https://brazilstockguide.com/insights/fleury-acquires-femme-laboratorio-da-mulher-for-207-million/
